Article: Synergistic Hydroxyl Radical Formation, System XC- Inhibition and Heat Shock Protein Crosslinking Tango in Ferrotherapy: A Prove-of-Concept Study of “Sword and Shield” Theory
View Paper Here Authors: Xie L, Chen W, Chen Q, Jiang Y, Song
VA Biofabrication Symposium
The first VA Biofabrication CoS Symposium will be held virtually May 4–5, 2022. We are excited to engage biofabrication researchers, practitioners, visionaries, and innovators like you to grow VA’s biofabrication efforts.
Join us for our panel discussion alongside Poietis on successful paths to commercialization on May 4th from 12:30 PM – 1:00 PM!
Biofabrication offers Veterans point-of-care solutions for the customized restoration of health. Through the VA Biofabrication Community of Science (Biofab CoS), VA is establishing an integrated infrastructure that aims to serve Veterans first with patient-matched biofabricated solutions.
Biofab CoS Provides:
- A platform for internal and external stakeholders to connect across the biofabrication continuum to learn, ideate, research, and build solutions for Veterans, together.
- A set of practices to develop biofabrication solutions across every stage of the development process and the eventual goal of first in-human clinical trials.
Biofab CoS Initiatives:
- Meetings provide regular touchpoints to stay up-to-date on internal and external activity in the biofabrication space.
- Annual VA Biofabrication Symposium convenes internal and external stakeholders working and/or interested in biofabrication.
Read more about Science!
Article: Bi-Functional Aspects of Peptide Decorated PLGA Nanocarriers for Enhanced Translocation Across the Blood-Brain Barrier through Macropinocytosis
View Paper Here Authors: Vijayan, A.N., Indrakumar, J., Gomathinayagam, S. et al. Bi-Functional Aspects of
Article: Dietary Supplementation with Nanoparticle CMCS-20a Enhances the Resistance to GCRV Infection in Grass Carp
View Paper Here Authors: Zhensheng Wang, Chuang Xu, Yanqi Zhang, Xingchen Huo, Jianguo
Advancing Hope: Preclinical Research in Childhood Cancer Awareness Month
Advancing Hope: Preclinical Research in Childhood Cancer Awareness Month September is a time
Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD- 1- based immunotherapy by increasing lymphocyte infiltration in colorectal cancer
Yibo Quan ,1 Jie He ,1,2 Qi Zou,1,2 Liuxi Zhang,1,2 Qihui Sun, 2
Allogeneic Expanded Human Peripheral NK Cells Control Prostate Cancer Growth in a Preclinical Mouse Model of Castration-Resistant Prostate Cancer
Fangming Wang, Xuejiao Dong, Jing Wang, Feiya Yang, Donghua Liu, Jianlin Ma, Shuai